Detalles de la búsqueda
1.
DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirine.
J Antimicrob Chemother
; 2024 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38884154
2.
Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.
J Antimicrob Chemother
; 76(9): 2400-2406, 2021 08 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34100068
3.
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?
J Antimicrob Chemother
; 75(1): 183-193, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31641777
4.
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients.
J Antimicrob Chemother
; 74(5): 1368-1375, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30789205
5.
Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France.
J Antimicrob Chemother
; 74(5): 1417-1424, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30753724
6.
New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017.
Euro Surveill
; 24(39)2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31576801
7.
Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen.
Clin Infect Dis
; 66(10): 1588-1594, 2018 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29244143
8.
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen.
J Antimicrob Chemother
; 73(4): 1039-1044, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29342281
9.
Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
J Antimicrob Chemother
; 72(8): 2351-2354, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28472307
10.
Ultradeep pyrosequencing of NS3 to predict response to triple therapy with protease inhibitors in previously treated chronic hepatitis C patients.
J Clin Microbiol
; 53(2): 389-97, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25411182
11.
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.
J Antimicrob Chemother
; 70(5): 1507-12, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25558077
12.
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma.
J Antimicrob Chemother
; 70(2): 566-72, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25344810
13.
Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.
J Clin Microbiol
; 51(9): 2815-21, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23616453
14.
HIV-1 load comparison using four commercial real-time assays.
J Clin Microbiol
; 49(1): 292-7, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21068276
15.
Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients.
Antimicrob Agents Chemother
; 54(1): 72-7, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19901096
16.
Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients.
Antimicrob Agents Chemother
; 52(9): 3237-43, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18625773
17.
Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network.
Antivir Ther
; 12(8): 1305-10, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18240870
18.
Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients.
J Clin Virol
; 95: 13-19, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28830014
19.
Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma.
PLoS One
; 12(4): e0174651, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28394908
20.
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure.
Int J Antimicrob Agents
; 42(1): 42-7, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23562640